Caroline Gallant

Caroline Gallant has a diverse work experience spanning over several years. Caroline is currently the Chief Technology Officer at Navinci Diagnostics since November 2022. Prior to this role, they worked at 10x Genomics for three years, starting in 2019. During their time at 10x Genomics, Caroline held the position of Director, R&D Stockholm, where they were responsible for the strategic direction and development of the company's European R&D site. Caroline also served as a Staff Scientist before taking on the director role.

Before joining 10x Genomics, Caroline worked at Uppsala University for nearly a decade. Caroline'sroles at the university included Assistant Professor and Group Leader, where they led a research group. Caroline also completed post-doctoral fellowships at Uppsala University, where they developed approaches for infectious disease detection and single cell proteomics, and McGill University, where they completed their Ph.D. at the Centre for the Study of Host Resistance.

Additionally, Caroline served as an Executive Board & Student Leader at Universities Allied for Essential Medicine from 2005 to 2009. Overall, their work experience demonstrates their expertise in technology innovation, strategic leadership, and research in various scientific domains.

Caroline Gallant's education history begins in 1997 when they attended CEGEP - John Abbott College, where they pursued a D.E.C in Liberal Arts & Sciences until 1999. Following that, they attended McGill University from 1999 to 2002, completing a B.Sc Honours degree in Biology. Later, they pursued a Ph.D. in Human Genetics at McGill University from 2003 to 2009. There is no available information regarding their education at Uppsala University.